Table 1
Stellar parameters.
| Star | M* (a) [M⊙] | AV [mag] | References | S/N(b) |
|---|---|---|---|---|
| TW Hya | 0.77 | 0.0 | McJ14, Ing13 | 1 |
| DM Tau | 0.50 | 0.0–1.5 | Carv22 | 0 |
| RECX 11 | 0.83 | 0.0–0.7 | McJ16, Fran23 | 1 |
| RECX 15 | 0.20 | 0.0 | Ing13, Rug18 | 1 |
| CVSO 90 | 0.62 | 0.0 | Cal05 | 6 |
| CVSO 109 | 0.46 | 0.1 | Fran23 | 13 |
| Sz 69 | 0.20 | 0.0 | Alc17 | 17 |
| Sz 77 | 0.75 | 0.0, 0.3 | Alc17, Fran23 | 3 |
| Sz 84 | 0.16 | 0.0 | Alc17 | 10 |
| Sz 97 | 0.23 | 0.0 | Alc17 | 14 |
| Sz 99 | 0.23 | 0.0 | Alc17 | 14 |
| Sz 100 | 0.16 | 0.0 | Alc17 | 8 |
| Sz 104 | 0.16 | 0.0 | Alc17 | 16 |
| Sz 110 | 0.22 | 0.0 | Alc17 | 10 |
| Sz 111 | 0.58 | 0.0, 0.85 | Alc17, Her14 | 0 |
| 2MASS J0439(c) | 0.17 | 0.0 | Fran23 | 17 |
| V510 Ori | 0.76 | 0.1 | Fran23 | 8 |
| AA Tau | 0.80 | 0.40–1.8 | Carv22 | 2 |
| CS Cha | 1.05 | 0.8 | Man17 | 0 |
| DE Tau | 0.59 | 0.3–0.89 | McJ16 | 2 |
| DK Tau A | 0.7 | 0.5–2.0 | Carv22 | 2 |
| DR Tau | 0.80 | 0.45–1.70 | Carv22 | 5 |
| DN Tau | 0.60 | 0.55 | Fran23, Her14 | 8 |
| HN Tau | 0.85 | 0.5–1.70 | Carv22 | 0 |
| MY Lup | 1.06 | 1.30 | Alc17 | 3 |
| RY Lup | 1.71 | 0.4 | Alc17 | 1 |
| SY Cha | 0.78 | 0.5 | Man17 | 1 |
| UX Tau A | 1.30 | 0.2–0.64 | McJ16, Fran23 | 5 |
| XX Cha | 0.29 | 0.3 | Fran23 | 2 |
| Sz 19 | 2.08 | 1.5 | Fran23 | 11 |
| Sz 45 | 0.56 | 0.7 | Fran23 | 3 |
| Sz 66 | 0.29 | 0.5, 1.0 | Her14, Alc17 | 2 |
| Sz 68 | 1.40 | 1.0 | Her14 | 4 |
| Sz 71 | 0.37 | 0.5, 0.7 | Alc17, Her14 | 5 |
| Sz 72 | 0.37 | 0.75 | Alc17 | 8 |
| Sz 75 | 0.82 | 1.0, 1.6 | Fran23, Her14 | 1 |
| Sz 98 | 0.70 | 1.0, 1.25 | Fran23,Her14 | 1 |
| Sz 102 | 0.24 | 0.71, 1.13 | Alc17, Fran23 | 1 |
| Sz 103 | 0.22 | 0.7, 0.85 | Alc17, Her14 | 0 |
| Sz 114 | 0.21 | 0.3 | Alc17 | 1 |
| Sz 129 | 0.79 | 0.90 | Alc17 | 1 |
| CHX 18n | 0.81 | 0.8 | Man17 | 3 |
| CVSO 58 | 0.81 | 0.8 | Fran23 | 11 |
| CVSO 107 | 0.53 | 0.3 | Fran23 | 10 |
| CVSO 146 | 0.86 | 0.6, 0.37 | Fran23, Cal05 | 4 |
| CVSO 176 | 0.25 | 1.0 | Fran23 | 7 |
| LkCa 15 | 0.85 | 0.3–1.1 | Carv22 | 2 |
| HN 5 | 0.18 | 1.1 | Fran23 | 11 |
| RX J1556.1–3655 | 0.5 | 0.6, 1.0 | Her14, Alc17 | 3 |
| sstc2d1608(d) | 1.4 | 0.2 | Alc17 | 5 |
| sstc2d1612(e) | 0.44 | 0.8 | Alc17 | 1 |
| V505 Ori | 0.81 | 1.0 | Fran23 | 10 |
Notes. Alc17: Alcalá et al. (2017), Cal05: Calvet et al. (2005), Carv22: Carvalho & Hillenbrand (2022), Fran23: France et al. (2023), Her14: Herczeg & Hillenbrand (2014), Ing13: Ingleby et al. (2013), Ken95: Kenyon & Hartmann (1995), McJ14: McJunkin et al. (2014), Man17: Manara et al. (2017), Rug18: Rugel et al. (2018). (a)From France et al. (2023). (b)Number of lines affected by S/N<10. (c)2MASS J04390163+2336029. (d)SSTc2d J160830.7–382827. (e)SSTc2d J161243.8–381503.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.